Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2025-12-30 @ 1:20 AM
Study NCT ID:
NCT01204866
Status:
COMPLETED
Last Update Posted:
2010-09-24
First Post:
2010-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use
Sponsor:
PharmAthene, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-16
First Submit QC Date:
None
Study First Post Date:
2010-09-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-09-23
Last Update Post Date:
2010-09-24
Last Update Post Date Type:
ESTIMATED